Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
OTOLARYNGOLOGY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
oral	O
cavity	O
cancer	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
s/p	O
composite	O
resection	O
oral	O
cavity,	O
angle	O
to	O
angle	O
mandibulectomy,	O
bilateral	O
neck	O
dissection,	O
left	O
fibula	O
free	O
flap,	O
split	O
thickness	O
skin	O
graft,	O
tracheostomy	O
on	O
___	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
female	O
T4	O
N1	O
M0	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
right	O
retromolar	O
trigone	O
and	O
mandible	O
extending	O
to	O
the	O
left	O
retromolar	O
trigone.	O
Past	O
Medical	O
History:	O
Hypertension	O
Hypercholesterolemia	O
S/p	O
hysterectomy	O
S/p	O
cholecystectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
3	O
sisters	O
have	O
breast	O
cancer,	O
no	O
family	O
history	O
of	O
heart	O
disease.	O
Physical	O
Exam:	O
Gen:	O
No	O
acute	O
distress	O
HEENT:	O
Neck	O
and	O
intraoral	O
incisions	O
clean	O
dry	O
and	O
intact.	O
Flap	O
warm,	O
well	O
perfused	O
without	O
signs	O
of	O
congestion,	O
strong	O
biphasic	O
Doppler.	O
Portex	O
6	O
trach	O
in	O
place	O
with	O
few	O
secretions.	O
CV:	O
Hemodynamically	O
stable	O
Resp:	O
Unlabored	O
breathing	O
Abd:	O
G-tube	O
in	O
position	O
Ext:	O
LLE	O
WWP,	O
skin	O
graft	O
healing	O
well	O
with	O
dressing	O
in	O
place.	O
Skin	O
graft	O
site	O
with	O
tegaderm.	O
Pertinent	O
Results:	O
___	O
07:00PM	O
BLOOD	O
WBC-7.3	O
RBC-2.71*	O
Hgb-8.6*	O
Hct-28.0*	O
MCV-103*	O
MCH-31.7	O
MCHC-30.7*	O
RDW-19.0*	O
RDWSD-69.8*	O
Plt	O
___	O
___	O
05:44AM	O
BLOOD	O
WBC-7.7	O
RBC-2.93*	O
Hgb-9.3*	O
Hct-28.2*	O
MCV-96	O
MCH-31.7	O
MCHC-33.0	O
RDW-18.6*	O
RDWSD-64.3*	O
Plt	O
___	O
___	O
06:17AM	O
BLOOD	O
WBC-7.3	O
RBC-2.99*	O
Hgb-9.3*	O
Hct-28.7*	O
MCV-96	O
MCH-31.1	O
MCHC-32.4	O
RDW-18.8*	O
RDWSD-66.4*	O
Plt	O
___	O
___	O
07:00PM	O
BLOOD	O
Plt	O
___	O
___	O
05:44AM	O
BLOOD	O
Plt	O
___	O
___	O
06:17AM	O
BLOOD	O
Plt	O
___	O
___	O
06:41AM	O
BLOOD	O
Glucose-161*	O
UreaN-16	O
Creat-0.5	O
Na-144	O
K-3.8	O
Cl-103	O
HCO3-31	O
AnGap-10	O
___	O
07:45PM	O
BLOOD	O
Glucose-172*	O
UreaN-14	O
Creat-0.5	O
Na-141	O
K-3.8	O
Cl-102	O
HCO3-31	O
AnGap-8*	O
___	O
05:50AM	O
BLOOD	O
Glucose-150*	O
UreaN-16	O
Creat-0.5	O
Na-145	O
K-3.3*	O
Cl-104	O
HCO3-33*	O
AnGap-8*	O
___	O
06:41AM	O
BLOOD	O
Albumin-2.6*	O
Calcium-7.7*	O
Phos-2.3*	O
Mg-1.9	O
___	O
07:45PM	O
BLOOD	O
Albumin-2.3*	O
Calcium-7.9*	O
Phos-2.0*	O
Mg-1.8	O
___	O
05:50AM	O
BLOOD	O
Albumin-2.5*	O
Calcium-8.2*	O
Phos-2.8	O
Mg-2.0	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
was	O
admitted	O
to	O
the	O
Otolaryngology-Head	O
and	O
Neck	O
Surgery	O
Service	O
after	O
composite	O
resection	O
oral	O
cavity,	O
angle	O
to	O
angle	O
mandibulectomy,	O
bilateral	O
neck	O
dissection,	O
left	O
fibula	O
free	O
flap,	O
split	O
thickness	O
skin	O
graft,	O
tracheostomy	O
on	O
___.	O
Please	O
see	O
the	O
separately	O
dictated	O
operative	O
note	O
for	O
details	O
of	O
procedure.	O
There	O
were	O
no	O
significant	O
intraoperative	O
complications.	O
Post-operatively,	O
patient	O
underwent	O
an	O
___	O
hospital	O
course.	O
ENT:	O
The	O
patient	O
had	O
a	O
composite	O
oral	O
cavity	O
tumor	O
resection	O
with	O
left	O
fibula	O
free	O
flap	O
for	O
reconstruction.	O
Patient	O
underwent	O
72	O
hours	O
of	O
Q1H	O
flap	O
checks	O
in	O
the	O
ICU	O
and	O
her	O
Doppler	O
pulse	O
remained	O
robust	O
throughout.	O
Neck	O
drains	O
were	O
sequentially	O
discontinued	O
once	O
they	O
met	O
drain	O
criteria	O
per	O
Plastics.	O
Patients	O
trach	O
was	O
downsized	O
to	O
a	O
Portex	O
6	O
cuffless	O
on	O
POD#5.	O
Patient	O
was	O
unable	O
to	O
tolerate	O
capping	O
trial	O
while	O
inpatient	O
due	O
to	O
frequent	O
suctioning	O
requirement	O
so	O
was	O
started	O
on	O
a	O
7	O
day	O
course	O
of	O
levaquin	O
with	O
improvement	O
in	O
secretions.	O
The	O
donor	O
skin	O
graft	O
site	O
was	O
covered	O
with	O
tegaderm	O
and	O
is	O
healing	O
well.	O
Daily	O
dressing	O
changes	O
were	O
performed	O
to	O
left	O
lower	O
leg	O
when	O
cast	O
came	O
down.	O
Neuro:	O
Patient	O
received	O
parenteral	O
and	O
then	O
enteral	O
narcotics	O
as	O
needed	O
for	O
pain	O
control	O
via	O
her	O
G	O
tube.	O
The	O
patient	O
was	O
at	O
baseline	O
neurologic	O
status.	O
Patient	O
is	O
to	O
continue	O
her	O
pain	O
regimen	O
and	O
wean	O
pain	O
medication	O
as	O
tolerated.	O
CV:	O
Patient	O
was	O
on	O
home	O
medications	O
throughout	O
the	O
hospital	O
stay.	O
Vitals	O
were	O
monitored	O
while	O
the	O
patient	O
was	O
hospitalized.	O
Patient's	O
vitals	O
were	O
within	O
normal	O
limits	O
on	O
discharge.	O
Pulm:	O
Patient	O
was	O
breathing	O
comfortably	O
on	O
RA	O
at	O
the	O
time	O
of	O
discharge	O
with	O
Portex	O
6	O
trach	O
in	O
place.	O
She	O
was	O
started	O
on	O
daily	O
IV	O
Lasix	O
for	O
volume	O
overload	O
and	O
worsening	O
pleural	O
effusions	O
on	O
serial	O
chest	O
X-rays.	O
Most	O
recent	O
Chest	O
X-ray	O
on	O
___	O
showed	O
improved	O
pulmonary	O
edema	O
and	O
improved	O
bilateral	O
pleural	O
effusions.	O
Creatinine	O
and	O
electrolytes	O
were	O
monitored	O
closely	O
and	O
replaced	O
as	O
necessary	O
while	O
on	O
Lasix.	O
GI:	O
Patient	O
must	O
remain	O
NPO	O
and	O
receive	O
all	O
medications	O
and	O
nutrition	O
through	O
G	O
tube	O
until	O
otherwise	O
stated	O
by	O
his	O
surgeon.	O
Renal/GU:	O
Patient	O
was	O
on	O
IVF	O
as	O
needed	O
with	O
electrolytes	O
repleted	O
prn.	O
Heme:	O
Pt	O
was	O
on	O
SCH	O
and	O
compression	O
boots	O
for	O
DVT	O
prophylaxis.	O
Patient	O
is	O
to	O
continue	O
ASA	O
81mg	O
QD	O
for	O
the	O
free	O
flap.	O
ID:	O
The	O
patient	O
was	O
on	O
perioperative	O
antibiotics	O
and	O
remained	O
afebrile	O
otherwise.	O
Endocrine:	O
The	O
patients	O
blood	O
glucose	O
was	O
checked	O
and	O
was	O
well	O
controlled	O
throughout	O
the	O
hospital	O
stay.	O
Physical	O
therapy:	O
Patient	O
was	O
seen	O
by	O
physical	O
therapy	O
who	O
recommend	O
continued	O
___	O
at	O
rehab.	O
Overall	O
the	O
patient	O
had	O
an	O
uneventful	O
recovery	O
and	O
is	O
being	O
discharged	O
to	O
rehab	O
in	O
stable	O
condition.	O
At	O
time	O
of	O
discharge,	O
the	O
patient	O
was	O
in	O
stable	O
condition,	O
ambulating	B-Mobile_with_assistance
and	O
voiding	O
with	B-Mobile_with_assistance
assist,	B-Mobile_with_assistance
and	O
with	O
adequate	O
pain	O
control.	O
The	O
patient	O
was	O
given	O
instructions	O
to	O
follow-up	O
in	O
clinic	O
as	O
scheduled.	O
Patient	O
was	O
given	O
detailed	O
discharge	O
instructions	O
outlining	O
wound	O
care,	O
activity,	O
diet,	O
follow-up	O
and	O
the	O
appropriate	O
medication	O
scripts.	O
Medications	O
on	O
Admission:	O
doxazosin	O
4	O
mg	O
tablet	O
daily	O
hydrochlorothiazide	O
25	O
mg	O
tablet	O
daily	O
lisinopril	O
40	O
mg	O
tablet	O
daily	O
lovastatin	O
20	O
mg	O
tablet	O
daily	O
metoprolol	O
succinate	O
ER	O
50	O
mg	O
tablet	O
daily	O
trazodone	O
50	O
mg	O
tablet	O
daily	O
PRN	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Furosemide	O
40	O
mg	O
PO/NG	O
DAILY	O
Duration:	O
3	O
Days	O
Crush	O
and	O
administer	O
through	O
G-tube.	O
Please	O
check	O
Creatinine	O
and	O
electrolytes	O
daily.	O
4.	O
Levofloxacin	O
750	O
mg	O
PO	O
Q24H	O
Duration:	O
7	O
Days	O
5.	O
Lidocaine	O
Jelly	O
2%	O
(Glydo)	O
1	O
Appl	O
TP	O
BID	O
PRN	O
pain	O
Apply	O
over	O
skin	O
graft	O
site	O
as	O
needed.	O
6.	O
Metoclopramide	O
10	O
mg	O
IV	O
Q8H:PRN	O
nausea	O
7.	O
Ondansetron	O
4	O
mg	O
IV	O
Q8H:PRN	O
nausea/vomiting	O
8.	O
TraMADol	O
50	O
mg	O
PO	O
Q8H:PRN	O
pain	O
9.	O
TraZODone	O
25	O
mg	O
PO	O
QHS:PRN	O
sleep	O
10.	O
Atorvastatin	O
20	O
mg	O
PO	O
QPM	O
11.	O
Doxazosin	O
4	O
mg	O
PO	O
DAILY	O
12.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
13.	O
Outpatient	O
Lab	O
Work	O
Please	O
draw	O
Creatinine	O
and	O
electrolytes	O
daily	O
while	O
giving	O
Lasix.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
oral	O
cavity	O
cancer	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Post-Operative	O
Instructions	O
Free	O
Tissue	O
Transplant	O
ACTIVITY	O
Go	O
home	O
and	O
rest	O
today.	O
Do	O
NOT	O
lift	O
any	O
weight	O
greater	O
than	O
10	O
Lbs	O
for	O
2	O
weeks.	O
FLUIDS	O
&	O
DIET	O
YOU	O
SHOULD	O
NOT	O
TAKE	O
ANY	O
FOOD	O
BY	O
MOUTH	O
You	O
have	O
a	O
G-tube	O
in	O
place.	O
Tube	O
feeds	O
should	O
be	O
placed	O
through	O
this	O
tube	O
as	O
instructed	O
in	O
the	O
hospital.	O
Formulas	O
should	O
be	O
given	O
at	O
room	O
temperature.	O
Cover	O
and	O
place	O
unused	O
formula	O
in	O
the	O
refrigerator.	O
FLUSHING	O
THE	O
G-tube	O
The	O
G-tube	O
should	O
be	O
periodically	O
flushed	O
with	O
clean	O
warm	O
water	O
to	O
keep	O
it	O
from	O
clogging.	O
Flush	O
the	O
tube	O
after	O
feedings	O
or	O
medications.	O
Draw	O
up	O
30	O
mL	O
of	O
warm	O
water	O
in	O
a	O
syringe.	O
Connect	O
the	O
syringe	O
to	O
the	O
tube	O
and	O
slowly	O
push	O
the	O
water	O
into	O
the	O
tube.	O
Flush	O
the	O
tube	O
gently	O
and	O
slowly.	O
GIVING	O
MEDICATION	O
In	O
general,	O
it	O
is	O
best	O
if	O
all	O
medications	O
are	O
in	O
a	O
liquid	O
form	O
for	O
G-tube	O
administration.	O
Liquid	O
medications	O
are	O
less	O
likely	O
to	O
clog	O
the	O
G-tube.	O
Mix	O
the	O
liquid	O
medication	O
with	O
30	O
mL	O
(or	O
amount	O
recommended	O
by	O
your	O
health	O
care	O
provider)	O
of	O
warm	O
water.	O
Draw	O
up	O
the	O
medication	O
into	O
the	O
syringe.	O
Attach	O
the	O
syringe	O
to	O
the	O
G-tube	O
and	O
slowly	O
push	O
the	O
mixture	O
into	O
the	O
G-tube.	O
After	O
giving	O
the	O
medication,	O
draw	O
up	O
30	O
mL	O
of	O
warm	O
water	O
in	O
the	O
syringe	O
and	O
slowly	O
flush	O
the	O
G-tube.	O
For	O
pills	O
or	O
capsules,	O
check	O
with	O
your	O
health	O
care	O
provider	O
first	O
before	O
crushing	O
medications.	O
Some	O
pills	O
are	O
not	O
effective	O
if	O
they	O
are	O
crushed.	O
Some	O
capsules	O
are	O
sustained-release	O
medications.	O
	O
If	O
appropriate,	O
crush	O
the	O
pill	O
or	O
capsule	O
and	O
mix	O
with	O
30	O
mL	O
of	O
warm	O
water.	O
Using	O
the	O
syringe,	O
slowly	O
push	O
the	O
medication	O
through	O
the	O
tube,	O
then	O
flush	O
the	O
tube	O
with	O
another	O
30	O
mL	O
of	O
tap	O
water.	O
MEDICATIONS	O
Take	O
pain	O
medication	O
as	O
prescribed.	O
Resume	O
other	O
medications	O
as	O
prescribed	O
except	O
any	O
aspirin	O
or	O
aspirin	O
containing	O
products	O
unless	O
cleared	O
by	O
your	O
surgeon.	O
CARE	O
OF	O
PROCEDURE	O
SITE	O
Some	O
swelling	O
of	O
the	O
face	O
and	O
any	O
incision	O
is	O
expected	O
You	O
may	O
note	O
some	O
bloody	O
looking	O
drainage	O
from	O
the	O
mouth	O
for	O
up	O
to	O
___	O
days.	O
	O
Apply	O
vaseline	O
ointment	O
to	O
any	O
skin	O
incision	O
twice	O
a	O
day.	O
	O
You	O
may	O
shower	O
	O
The	O
xeroform	O
over	O
leg	O
dressing	O
will	O
slowly	O
peel	O
off.	O
You	O
can	O
cut	O
off	O
the	O
edges	O
as	O
it	O
peels	O
away	O
WHEN	O
TO	O
CALL	O
YOUR	O
DOCTOR	O
Excessive	O
redness	O
of	O
your	O
incision	O
site	O
Fever	O
greater	O
than	O
101	O
degrees	O
Fahrenheit	O
Sudden	O
excessive	O
swelling	O
of	O
incision	O
site	O
For	O
questions	O
or	O
problems,	O
please	O
call	O
___	O
to	O
speak	O
to	O
the	O
clinic	O
nurse	O
during	O
clinic	O
hours.	O
FOR	O
ALL	O
WOUND	O
QUESTIONS	O
(INCLUDING	O
ORAL,	O
NECK,	O
AND	O
LEG	O
WOUNDS)	O
PLEASE	O
CALL	O
PLASTICS	O
AT	O
___.	O
After	O
hours,	O
or	O
on	O
weekends,	O
dial	O
___	O
and	O
ask	O
the	O
operator	O
to	O
page	O
the	O
Plastics	O
resident	O
on-call.	O
Followup	O
Instructions:	O
___	O

